Akeso, Inc. (HKG:9926)

Hong Kong · Delayed Price · Currency is HKD

93.60

-1.45 (-1.53%)

Sep 10, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Research, Development, Production and Sale of Biopharmaceutical Products	3.06B	2.12B	4.53B	837.66M	225.63M
Total	3.06B	2.12B	4.53B	837.66M	225.63M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Mainland China	2.70B	1.88B	1.59B	837.66M	97.03M
United States of America (USA)	338.52M	243.64M	2.93B	-	128.60M
Other Regions	17.50M	2.26M	1.20M	-	-
Total	3.06B	2.12B	4.53B	837.66M	225.63M